Title : Systematic review of resistance to fluconazole for clinical isolates of the Candida albicans species diagnosed in the HCA parasitology mycology laboratory
Abstract:
The incidence of mycoses caused by Candida spp. has increased steadily over the past two decades, Candida albicans remains the most commonly isolated microscopic fungus. The objective of our study was to identify the profile of a few strains of Candida albicans isolated from different samples and to study resistance to Fluconazole over a period of 1 year from 2021 to 2022. The identification of 70 strains was done according to conventional methods, their sensitivity and resistance to antifungals was also evaluated by Vitek2 Semi-liquid Microdilution (AST-YS06 card) and FUNGITEST Bio Rad gallery. The antifungals tested were Amphotericin B, 5-fluorocytosine, azoles and echinochandins. The C. albicans strains had variable sensitivity: 100% to amphotericin B (MIC90 = 0.5 μg/mL); 99% to 5-fluorocytosine (MIC90 = 4 μg/mL); 86.7% to voriconazole (MIC50 = 0.06 μg/mL) and 80% to fluconazole (MIC50 = 2 μg/mL and MIC90 = 32 μg/m). In addition to the intrinsic resistance of the species studied, we noted the emergence of acquired resistance including resistance to some azoles Fluconazole (n=5), Itraconazol (n=4), Miconazole (n=5), Ketoconazole (n=2), and Voriconazole (n=1). Our study showed that C. albicans was the most incriminated strain. However, an emergence of acquired resistance is starting, hence the importance of carrying out an antifungigram in order to monitor these resistance profiles.